-
1
-
-
38849147752
-
Ral GTPases and cancer: Linchpin support of the tumorigenic platform
-
Bodemann BO and White MA (2008). Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat Rev Cancer 8, 133-140.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 133-140
-
-
Bodemann, B.O.1
White, M.A.2
-
2
-
-
0029950722
-
A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation
-
White MA, Vale T, Camonis JH, Schaefer E, and Wigler MH (1996). A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J Biol Chem 271, 16439-16442.
-
(1996)
J Biol Chem
, vol.271
, pp. 16439-16442
-
-
White, M.A.1
Vale, T.2
Camonis, J.H.3
Schaefer, E.4
Wigler, M.H.5
-
3
-
-
20444410041
-
Activation of RalA is critical for Ras-induced tumorigenesis of human cells
-
Lim KH, Baines AT, Fiordalisi JJ, Shipitsin M, Feig LA, Cox AD, Der CJ, and Counter CM (2005). Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 7, 533-545.
-
(2005)
Cancer Cell
, vol.7
, pp. 533-545
-
-
Lim, K.H.1
Baines, A.T.2
Fiordalisi, J.J.3
Shipitsin, M.4
Feig, L.A.5
Cox, A.D.6
Der, C.J.7
Counter, C.M.8
-
4
-
-
33845448647
-
Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells
-
Lim KH, O'Hayer K, Adam SJ, Kendall SD, Campbell PM, Der CJ, and Counter CM (2006). Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr Biol 16, 2385-2394.
-
(2006)
Curr Biol
, vol.16
, pp. 2385-2394
-
-
Lim, K.H.1
O'Hayer, K.2
Adam, S.J.3
Kendall, S.D.4
Campbell, P.M.5
Der, C.J.6
Counter, C.M.7
-
5
-
-
35648970538
-
Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone
-
Yin J, Pollock C, Tracy K, Chock M, Martin P, Oberst M, and Kelly K (2007). Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone. Mol Cell Biol 27, 7538-7550.
-
(2007)
Mol Cell Biol
, vol.27
, pp. 7538-7550
-
-
Yin, J.1
Pollock, C.2
Tracy, K.3
Chock, M.4
Martin, P.5
Oberst, M.6
Kelly, K.7
-
6
-
-
34447133481
-
Expression of ral GTPases, their effectors, and activators in human bladder cancer
-
Smith SC, Oxford G, Baras AS, Owens C, Havaleshko D, Brautigan DL, Safo MK, and Theodorescu D (2007). Expression of ral GTPases, their effectors, and activators in human bladder cancer. Clin Cancer Res 13, 3803-3813.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 3803-3813
-
-
Smith, S.C.1
Oxford, G.2
Baras, A.S.3
Owens, C.4
Havaleshko, D.5
Brautigan, D.L.6
Safo, M.K.7
Theodorescu, D.8
-
7
-
-
23844472876
-
RalA and RalB: Antagonistic relatives in cancer cell migration
-
Oxford G, Owens CR, Titus BJ, Foreman TL, Herlevsen MC, Smith SC, and Theodorescu D (2005). RalA and RalB: antagonistic relatives in cancer cell migration. Cancer Res 65, 7111-7120.
-
(2005)
Cancer Res
, vol.65
, pp. 7111-7120
-
-
Oxford, G.1
Owens, C.R.2
Titus, B.J.3
Foreman, T.L.4
Herlevsen, M.C.5
Smith, S.C.6
Theodorescu, D.7
-
8
-
-
33644530955
-
Regression of melanoma in a murine model by RLIP76 depletion
-
Singhal SS, Awasthi YC, and Awasthi S (2006). Regression of melanoma in a murine model by RLIP76 depletion. Cancer Res 66, 2354-2360.
-
(2006)
Cancer Res
, vol.66
, pp. 2354-2360
-
-
Singhal, S.S.1
Awasthi, Y.C.2
Awasthi, S.3
-
9
-
-
34249322665
-
Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1)
-
Singhal SS, Singhal J, Yadav S, Dwivedi S, Boor PJ, Awasthi YC, and Awasthi S (2007). Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1). Cancer Res 67, 4382-4389.
-
(2007)
Cancer Res
, vol.67
, pp. 4382-4389
-
-
Singhal, S.S.1
Singhal, J.2
Yadav, S.3
Dwivedi, S.4
Boor, P.J.5
Awasthi, Y.C.6
Awasthi, S.7
-
10
-
-
0028921344
-
Ras mediates the activation of phospholipase D by v-Src
-
Jiang H, Lu Z, Luo JQ, Wolfman A, and Foster DA (1995). Ras mediates the activation of phospholipase D by v-Src. J Biol Chem 270, 6006-6009.
-
(1995)
J Biol Chem
, vol.270
, pp. 6006-6009
-
-
Jiang, H.1
Lu, Z.2
Luo, J.Q.3
Wolfman, A.4
Foster, D.A.5
-
11
-
-
0034795116
-
Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts
-
Min DS, Kwon TK, Park WS, Chang JS, Park SK, Ahn BH, Ryoo ZY, Lee YH, Lee YS, Rhie DJ, et al. (2001). Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts. Carcinogenesis 22, 1641-1647.
-
(2001)
Carcinogenesis
, vol.22
, pp. 1641-1647
-
-
Min, D.S.1
Kwon, T.K.2
Park, W.S.3
Chang, J.S.4
Park, S.K.5
Ahn, B.H.6
Ryoo, Z.Y.7
Lee, Y.H.8
Lee, Y.S.9
Rhie, D.J.10
-
12
-
-
2442562277
-
A novel triple- modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging
-
Ponomarev V, Doubrovin M, Serganova I, Vider J, Shavrin A, Beresten T, Ivanova A, Ageyeva L, Tourkova V, Balatoni J, et al. (2004). A novel triple- modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur J Nucl Med Mol Imaging 31, 740-751.
-
(2004)
Eur J Nucl Med Mol Imaging
, vol.31
, pp. 740-751
-
-
Ponomarev, V.1
Doubrovin, M.2
Serganova, I.3
Vider, J.4
Shavrin, A.5
Beresten, T.6
Ivanova, A.7
Ageyeva, L.8
Tourkova, V.9
Balatoni, J.10
-
13
-
-
0037112363
-
RhoGDI2 is an invasion and metastasis suppressor gene in human cancer
-
Gildea JJ, Seraj MJ, Oxford G, Harding MA, Hampton GM, Moskaluk CA, Frierson HF, Conaway MR, and Theodorescu D (2002). RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 62, 6418-6423.
-
(2002)
Cancer Res
, vol.62
, pp. 6418-6423
-
-
Gildea, J.J.1
Seraj, M.J.2
Oxford, G.3
Harding, M.A.4
Hampton, G.M.5
Moskaluk, C.A.6
Frierson, H.F.7
Conaway, M.R.8
Theodorescu, D.9
-
14
-
-
11144231663
-
Combination antiangiogenic and androgen deprivation therapy for prostate cancer: A promising therapeutic approach
-
Nicholson B, Gulding K, Conaway M, Wedge SR, and Theodorescu D (2004). Combination antiangiogenic and androgen deprivation therapy for prostate cancer: a promising therapeutic approach. Clin Cancer Res 10, 8728-8734.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 8728-8734
-
-
Nicholson, B.1
Gulding, K.2
Conaway, M.3
Wedge, S.R.4
Theodorescu, D.5
-
15
-
-
33846846542
-
Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia
-
Wu Y, McRoberts K, Berr SS, Frierson HF Jr, Conaway M, and Theodorescu D (2007). Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia. Oncogene 26, 765-773.
-
(2007)
Oncogene
, vol.26
, pp. 765-773
-
-
Wu, Y.1
McRoberts, K.2
Berr, S.S.3
Frierson Jr., H.F.4
Conaway, M.5
Theodorescu, D.6
-
16
-
-
7444244492
-
Profiling the evolution of human metastatic bladder cancer
-
Nicholson BE, Frierson HF, Conaway MR, Seraj JM, Harding MA, Hampton GM, and Theodorescu D (2004). Profiling the evolution of human metastatic bladder cancer. Cancer Res 64, 7813-7821.
-
(2004)
Cancer Res
, vol.64
, pp. 7813-7821
-
-
Nicholson, B.E.1
Frierson, H.F.2
Conaway, M.R.3
Seraj, J.M.4
Harding, M.A.5
Hampton, G.M.6
Theodorescu, D.7
-
17
-
-
0035887459
-
Molecular classification of human carcinomas by use of gene expression signatures
-
Su AI, Welsh JB, Sapinoso LM, Kern SG, Dimitrov P, Lapp H, Schultz PG, Powell SM, Moskaluk CA, Frierson HF Jr, et al. (2001). Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 61, 7388-7393.
-
(2001)
Cancer Res
, vol.61
, pp. 7388-7393
-
-
Su, A.I.1
Welsh, J.B.2
Sapinoso, L.M.3
Kern, S.G.4
Dimitrov, P.5
Lapp, H.6
Schultz, P.G.7
Powell, S.M.8
Moskaluk, C.A.9
Frierson Jr., H.F.10
-
18
-
-
27644506613
-
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
-
Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ, et al. (2005). Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8, 393-406.
-
(2005)
Cancer Cell
, vol.8
, pp. 393-406
-
-
Varambally, S.1
Yu, J.2
Laxman, B.3
Rhodes, D.R.4
Mehra, R.5
Tomlins, S.A.6
Shah, R.B.7
Chandran, U.8
Monzon, F.A.9
Becich, M.J.10
-
19
-
-
51649103801
-
RLIP76 and cancer
-
Awasthi S, Singhal SS, Awasthi YC, Martin B, Woo JH, Cunningham CC, and Frankel AE (2008). RLIP76 and cancer. Clin Cancer Res 14, 4372-4377.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 4372-4377
-
-
Awasthi, S.1
Singhal, S.S.2
Awasthi, Y.C.3
Martin, B.4
Woo, J.H.5
Cunningham, C.C.6
Frankel, A.E.7
-
20
-
-
0029089074
-
Bridging Ral GTPase to Rho pathways.RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity
-
Jullien-Flores V, Dorseuil O, Romero F, Letourneur F, Saragosti S, Berger R, Tavitian A, Gacon G, and Camonis JH (1995). Bridging Ral GTPase to Rho pathways. RLIP76, a Ral effector with CDC42/Rac GTPase-activating protein activity. J Biol Chem 270, 22473-22477.
-
(1995)
J Biol Chem
, vol.270
, pp. 22473-22477
-
-
Jullien-Flores, V.1
Dorseuil, O.2
Romero, F.3
Letourneur, F.4
Saragosti, S.5
Berger, R.6
Tavitian, A.7
Gacon, G.8
Camonis, J.H.9
-
21
-
-
70449091786
-
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
-
Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, Schinzel AC, Sandy P, Meylan E, Scholl C, et al. (2009). Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108-112.
-
(2009)
Nature
, vol.462
, pp. 108-112
-
-
Barbie, D.A.1
Tamayo, P.2
Boehm, J.S.3
Kim, S.Y.4
Moody, S.E.5
Dunn, I.F.6
Schinzel, A.C.7
Sandy, P.8
Meylan, E.9
Scholl, C.10
-
22
-
-
33749165933
-
RalB GTPase-mediated activation of the IκB family kinase TBK1 couples innate immune signaling to tumor cell survival
-
Chien Y, Kim S, Bumeister R, Loo YM, Kwon SW, Johnson CL, Balakireva MG, Romeo Y, Kopelovich L, Gale M Jr, et al. (2006). RalB GTPase-mediated activation of the IκB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 127, 157-170.
-
(2006)
Cell
, vol.127
, pp. 157-170
-
-
Chien, Y.1
Kim, S.2
Bumeister, R.3
Loo, Y.M.4
Kwon, S.W.5
Johnson, C.L.6
Balakireva, M.G.7
Romeo, Y.8
Kopelovich, L.9
Gale Jr., M.10
-
23
-
-
73549119929
-
Aurora-A phosphorylates, activates and relocalizes RalA
-
Lim KH, Brady DC, Kashatus DF, Ancrile BB, Der CJ, Cox AD, and Counter CM (2010). Aurora-A phosphorylates, activates and relocalizes RalA. Mol Cell Biol 30, 508-523.
-
(2010)
Mol Cell Biol
, vol.30
, pp. 508-523
-
-
Lim, K.H.1
Brady, D.C.2
Kashatus, D.F.3
Ancrile, B.B.4
Der, C.J.5
Cox, A.D.6
Counter, C.M.7
-
24
-
-
70349780603
-
Regulated RalBP1 binding to RalA and PSD-95 controls AMPA receptor endocytosis and LTD
-
Han K, Kim MH, Seeburg D, Seo J, Verpelli C, Han S, Chung HS, Ko J, Lee HW, Kim K, et al. (2009). Regulated RalBP1 binding to RalA and PSD-95 controls AMPA receptor endocytosis and LTD. PLoS Biol 7, e1000187.
-
(2009)
PLoS Biol
, vol.7
-
-
Han, K.1
Kim, M.H.2
Seeburg, D.3
Seo, J.4
Verpelli, C.5
Han, S.6
Chung, H.S.7
Ko, J.8
Lee, H.W.9
Kim, K.10
|